Health-Focused PE Firm 1315 Capital Closes $300M Fund

Law360 (February 12, 2018, 1:52 PM EST) -- Philadelphia-based private investment firm 1315 Capital, which specializes in medical technology companies, has closed its second fund at more than $300 million, the company said Monday.

1315 Capital LLC closed the fund, 1315 Capital II, with contributions totaling more than $300 million, which exceeded the $250 million target. 1315 Capital II is a health care growth equity fund and includes public and private pension and family office limited partners. The company could not confirm a specific value for the fund.

“We appreciate the ongoing partnership with...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.